What is Kyverna Therapeutics, Inc. Common Stock's Market Cap?

Kyverna Therapeutics, Inc. Common Stock's Market Cap is $489.5M, based on as-reported figures from SEC (XBRL) filings.

What is Kyverna Therapeutics, Inc. Common Stock's Enterprise Value?

Kyverna Therapeutics, Inc. Common Stock's Enterprise Value is $315.1M, based on as-reported figures from SEC (XBRL) filings.

What is Kyverna Therapeutics, Inc. Common Stock's EV / EBITDA?

Kyverna Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Kyverna Therapeutics, Inc. Common Stock's Net Income (TTM)?

Kyverna Therapeutics, Inc. Common Stock's Net Income (TTM) is -$152.6M, based on as-reported figures from SEC (XBRL) filings.

What is Kyverna Therapeutics, Inc. Common Stock's EBITDA?

Kyverna Therapeutics, Inc. Common Stock's EBITDA is -$157.4M, based on as-reported figures from SEC (XBRL) filings.

What is Kyverna Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Kyverna Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.47, based on as-reported figures from SEC (XBRL) filings.

What is Kyverna Therapeutics, Inc. Common Stock's Net Debt?

Kyverna Therapeutics, Inc. Common Stock's Net Debt is -$174.4M, based on as-reported figures from SEC (XBRL) filings.

Kyverna Therapeutics, Inc. Common Stock (KYTX) Financial Statements

Kyverna Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00RCYMHS0

XNAS · usd

7.92▼ 0.16 (-1.92%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close8.07

Day's Range7.97 – 8.21

52-Week Range3.72 – 13.67

Volume582.8K

Avg Volume712.8K

Share Statistics

Shares Outstanding

Employees130

ExchangeXNAS

Listed2024-02-08

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Kyverna Therapeutics, Inc. Common Stock (KYTX)

What is Kyverna Therapeutics, Inc. Common Stock's Market Cap?: Kyverna Therapeutics, Inc. Common Stock's Market Cap is $489.5M, based on as-reported figures from SEC (XBRL) filings.
What is Kyverna Therapeutics, Inc. Common Stock's Enterprise Value?: Kyverna Therapeutics, Inc. Common Stock's Enterprise Value is $315.1M, based on as-reported figures from SEC (XBRL) filings.
What is Kyverna Therapeutics, Inc. Common Stock's EV / EBITDA?: Kyverna Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Kyverna Therapeutics, Inc. Common Stock's Net Income (TTM)?: Kyverna Therapeutics, Inc. Common Stock's Net Income (TTM) is -$152.6M, based on as-reported figures from SEC (XBRL) filings.
What is Kyverna Therapeutics, Inc. Common Stock's EBITDA?: Kyverna Therapeutics, Inc. Common Stock's EBITDA is -$157.4M, based on as-reported figures from SEC (XBRL) filings.
What is Kyverna Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Kyverna Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.47, based on as-reported figures from SEC (XBRL) filings.
What is Kyverna Therapeutics, Inc. Common Stock's Net Debt?: Kyverna Therapeutics, Inc. Common Stock's Net Debt is -$174.4M, based on as-reported figures from SEC (XBRL) filings.